Video walkthrough
Prescribing worked through on the exam interface, with the BNF open, in 10 min.
At a glance
| Question style | Free-text prescription on the exam's chart |
|---|---|
| What you do | Write one prescription on the chart: medicine, dose, route, frequency |
| Primary skill | Choosing the right drug, then writing it safely |
| BNF use | Indications and dose, renal and hepatic impairment, contra-indications |
| On PassthePSA | The same chart. Marked in two halves, component by component, with partial credit and the marking tier shown. 187 questions in this section, rated easy to hard. |
What this section is really testing
- Recognising the clinical problem that needs a drug now, and which one. The case usually contains the indication in plain sight; the discrimination is between the credited drug and its near neighbours.
- Writing the prescription as a prescription, not as a drug name: a dose in the right unit, a route the drug can actually be given by, a frequency, and where the scheme states one, a duration.
- Applying the patient to the dose: weight, age, renal function, pregnancy, and the interaction that changes the usual choice.
- Using the chart correctly. Once-only, regular and as-required sections are different forms, and the instruction line tells you which one the marks are on.
A repeatable approach
- Name the indicationSay in one phrase what the drug is for. If you cannot, you are not ready to choose one.
- Choose the class, then the drugThe BNF treatment summary gives the class and first-line agent; the case's modifiers pick the drug within it.
- Find the dose under the right indicationMonographs list several indications with different doses. Read the heading, not the first number.
- Apply the patientWeight-based? Renal impairment? Age band? Pregnancy? Each can change the dose or the drug.
- Write it as the chart needs itDose in a unit, route from the accepted list, frequency in words the chart uses, once-only or regular as instructed.
Using the BNF for this section
The exam is open book, and the time is short. Know which heading answers which question before you open the monograph.
| If you need to know | Look under |
|---|---|
| What should I give for this condition? | Treatment summaries |
| How much, how often? | Indications and dose, under the matching indication |
| The eGFR is low | Renal impairment |
| Liver disease | Hepatic impairment |
| Is there a reason not to? | Contra-indications, then cautions |
| They are on something that clashes | Interactions |
The general technique, with timed lookups, is in the BNF guide.
The anatomy of a credited prescription
Every prescribing item is marked in two halves, and the halves are independent. You can score full marks for the drug and nothing for the prescription, or the reverse.
The final prescription check
- Correct patient: weight, age, pregnancy, allergy
- Correct medicine, generic, for this indication
- Correct dose from the matching indication, in a unit
- Correct route for this form
- Correct frequency, and duration if the scheme wants one
- Renal or hepatic adjustment applied
- Contra-indications and allergy checked
- Interactions with the chart checked
Common traps
| Trap | Why it costs marks |
|---|---|
| Volume instead of dose | 0.5 mL is not a dose. Write the amount of drug in mass or units; a volume without a strength is how tenfold errors happen. |
| Wrong indication, wrong dose | The same drug appears with several doses. The dose for the indication in the question is the only credited one. |
| Right drug, wrong section of the chart | A once-only drug written as a regular prescription, or the reverse, loses the prescription marks. |
| Frequency left blank | A blank is marked as wrong, not as unstated. If the scheme states a frequency, it is required. |
| Route the drug cannot take | Oral for a drug that only exists as an injection, or IV for a depot. Check the medicinal forms if unsure. |
| Hedging with two drugs | Writing two medicines in one box scores nothing for the box. Commit to one. |
Areas worth being comfortable with
Not predictions. These are the broad clinical areas this section draws on, taken from the shape of the exam and the BNF; being fluent in them makes the lookup fast.
- Analgesia, including the WHO ladder and opioid conversion
- Antibiotics for common community and hospital infections
- Anticoagulation: initiation, reversal and bridging
- Fluids and electrolyte replacement
- Diabetes: insulin regimens and hypoglycaemia
- Asthma and COPD acute treatment
- Anaphylaxis and other emergency once-only drugs
- Nausea, constipation and other symptom control
- Steroids: dosing and sick-day rules
- Thromboprophylaxis
What this section covers in the bank
Topics with the most prescribing questions at the last build, counted by the app's topic search; each link opens that topic in the app.
- Infection and antibiotics · 56
- Steroids and adrenal · 35
- Pain and opioids · 27
- Stomach, bowel and nausea · 26
- Potassium, sodium and electrolytes · 22
- Atrial fibrillation and anticoagulants · 21
- Pregnancy, breastfeeding and contraception · 20
- Children and paediatrics · 14
Worked examples
These are real questions from the PassthePSA bank, free to every visitor. Work each one with the BNF open before you show the answer; at exam pace a 10-mark item has 6 minutes.
Thromboprophylaxis for a 58-year-old admitted with pneumonia
Case
A 58-year-old man is admitted to the acute medical unit with community-acquired pneumonia. He is breathless walking to the bathroom and is expected to spend most of the next few days in bed. The admission venous thromboembolism risk assessment scores him at increased risk of thrombosis and low risk of bleeding, and the consultant asks for pharmacological thromboprophylaxis to be prescribed alongside the antibiotic. He has never had a thrombosis and has never taken an anticoagulant.
PMH: Type 2 diabetes mellitus; hypertension.
DH: metformin 500 mg PO twice daily (12-hrly); amlodipine 5 mg PO daily; doxycycline 200 mg PO today, then 100 mg PO once daily (started today for the pneumonia; atypical pneumonia suspected). No known drug allergies.
SH: non-smoker; drinks 8 units of alcohol a week; delivery driver.
On examination: Temperature 38.1°C, HR 96/min and regular, BP 128/76 mmHg, RR 22/min, O2 sat 94% breathing air. Weight 82 kg. Right basal crackles with dullness to percussion. No calf swelling or tenderness. No rash, no bruising, no bleeding.
Investigations: Na 136 mmol/L (135–145) K 4.2 mmol/L (3.5–5.3) Urea 6.2 mmol/L (2.5–7.8) Creatinine 76 µmol/L (60–120) Hb 148 g/L (130–180) WCC 13.6 ×10⁹/L (4.0–11.0) Platelets 322 ×10⁹/L (150–400) CRP 118 mg/L (<5) Chest X-ray: right lower lobe consolidation
Question
Write a prescription for the ONE drug that is most appropriate to reduce his risk of venous thromboembolism during this admission.
(use the hospital 'regular medicines' prescription form provided)
Your answer: one written prescription, giving the medicine, dose, route and frequency.
Show the answer and markingHide the answer
enoxaparin sodium 40 mg/0.4 mL pre-filled syringe (Clexane®) · 40 mg · subcutaneous (SC) · once daily
Marks5 for the drug choice, 5 for the written prescription (dose, route, frequency).
Also creditedenoxaparin; enoxaparin sodium; Clexane; Inhixa; dalteparin; dalteparin sodium; Fragmin
Drug choiceAn acutely ill medical inpatient whose mobility has just collapsed is exactly who pharmacological thromboprophylaxis is for, and the risk assessment printed with the case has already made the decision to treat — increased thrombosis risk, low bleeding risk. The UK answer is a low molecular weight heparin, and the BNF doses two of them for this precise indication: enoxaparin 40 mg every 24 hours, dalteparin 5000 units every 24 hours, both subcutaneous. Either earns full marks. Fondaparinux 2.5 mg once daily is a licensed, NICE-listed alternative and loses one mark on drug choice only. Tinzaparin is the trap inside the class: its prophylaxis licences are surgical (3500 units general surgery, 4500 units orthopaedic) and it has no medical-patient dose to write. Unfractionated heparin 5000 units twice daily is kept for patients who cannot have a low molecular weight heparin — severe renal impairment, mainly — and this man's creatinine clearance is about 109 mL/minute. The direct oral anticoagulants fail on licence: rivaroxaban and apixaban cover prophylaxis only after hip or knee replacement, and trials of extended oral prophylaxis in medical patients bought extra bleeding for no net benefit. Aspirin is an antiplatelet, and NICE NG89 says in terms not to use it for this purpose.
ExplanationHis doxycycline does not change the choice. The BNF interaction checker flags a theoretical risk of hepatotoxicity when doxycycline is given with HIGH-DOSE enoxaparin or dalteparin; it attaches the same flag to dozens of drugs, including paracetamol. A 40 mg prophylactic dose of enoxaparin is the lowest adult dose, not a high dose, and unfractionated heparin carries an unqualified version of the same warning, so switching would not avoid it.
The dose is 40 mg — or, as the Clexane SmPC itself writes it, 4,000 IU — subcutaneously once daily. The number that catches people is 20. Twenty milligrams is a real enoxaparin dose twice over: the moderate-risk surgical dose, and the prophylaxis dose when creatinine clearance falls to 15–30 mL/minute. Neither applies to a 58-year-old with a creatinine of 76 µmol/L, and half-dose prophylaxis in normal renal function is under-protection. In the other direction, 1 mg/kg twice daily and 1.5 mg/kg once daily are TREATMENT doses — for a thrombosis he does not have — and score nothing for the prescription half, as does 40 mg written twice daily, which is the same 80 mg a day by another route. Check the platelet count before starting any heparin (his is 322 ×10⁹/L, printed) and remember the count needs rechecking if he is still on it after 4 days.
Credited answersenoxaparin sodium 40 mg/0.4 mL pre-filled syringe (Clexane®/Inhixa®) — 40 mg (4,000 units), subcutaneous (SC), once daily. Full marks. dalteparin sodium 5000 units/0.2 mL (Fragmin®) — 5000 units, subcutaneous (SC), once daily. Full marks. Also credited for drug choice: fondaparinux 2.5 mg SC once daily (4 + 5); unfractionated heparin 5000 units SC twice daily (2 + 5); tinzaparin (3 + 0); 'low molecular weight heparin' unnamed (2 + 0). rivaroxaban, apixaban, warfarin, aspirin — 0/10. (BNF, enoxaparin sodium and dalteparin sodium monographs, and Clexane SmPC, all read 22 August 2026.)
How this item is marked
Every answer is matched to a marking tier. These are the first rows of this item's real scheme (33 tiers in total).
| Medicine | Dose and route | Marks | Marking note |
|---|---|---|---|
| enoxaparin | 40 mg · subcutaneous (SC) | 10 / 10 | optimal. BNF, prophylaxis of deep-vein thrombosis in medical patients: 'By subcutaneous injection, Adult: 40 mg every 24 hours.' Normal renal function (Cockcrof… |
| enoxaparin | 4000 units · subcutaneous (SC) | 10 / 10 | the same dose written in units — the Clexane SmPC's own spelling is '4,000 IU (40 mg) once daily'. |
| Clexane | 40 mg · subcutaneous (SC) | 10 / 10 | the same prescription under the brand name; biological medicines are in any case prescribed by brand. Credited identically. |
| Inhixa | 40 mg · subcutaneous (SC) | 10 / 10 | the biosimilar brand. Credited identically. |
| dalteparin | 5000 units · subcutaneous (SC) | 10 / 10 | the co-equal alternative: BNF, prophylaxis of deep-vein thrombosis in medical patients, 'By subcutaneous injection, Adult: 5000 units every 24 hours.' Any UK tr… |
| Fragmin | 5000 units · subcutaneous (SC) | 10 / 10 | dalteparin under its brand name. Credited identically. |
| enoxaparin | 20 mg · subcutaneous (SC) | 6 / 10 | the renal-impairment dose (creatinine clearance 15–30 mL/minute) or the moderate-risk surgical dose, given to a man whose creatinine clearance is about 109 mL/m… |
| enoxaparin | 2000 units · subcutaneous (SC) | 6 / 10 | the same under-dose written in units (2,000 IU = 20 mg). Deduct 4. |
© 2026 PassthePSA · Question PWS-87 · Free sample for personal study. Copying, republishing or AI training use is not permitted (terms).
A 66-year-old with chronic kidney disease, weakness and palpitations after a new antibiotic
Case
A 66-year-old man is brought to the emergency department with two days of worsening weakness and palpitations. He has chronic kidney disease, and three days ago his general practitioner started an antibiotic for a urinary tract infection. He is on a cardiac monitor in the resuscitation area with resuscitation staff present.
PMH: Chronic kidney disease; hypertension; benign prostatic enlargement.
DH: ramipril 5 mg PO daily; trimethoprim 200 mg PO twice daily (12-hrly), day 3 of 7; atorvastatin 20 mg PO nightly; tamsulosin 400 micrograms PO daily. No known drug allergies.
SH: retired; lives with his wife; non-smoker.
On examination: Temperature 36.9°C, HR 88/min and regular, BP 138/84 mmHg, RR 16/min, O2 sat 97% breathing air. Alert and orientated. Proximal muscle weakness in both legs; reflexes present. Chest clear, JVP not raised, no oedema. Abdomen soft; bladder not palpable. A 22-gauge cannula is sited in the back of the left hand and flushes easily. He is attached to a cardiac monitor.
Investigations: Na 134 mmol/L (135–145) K 7.1 mmol/L (3.5–5.3) Bicarbonate 17 mmol/L (22–29) Urea 21.4 mmol/L (2.5–7.8) Creatinine 187 µmol/L (60–120), eGFR 34 mL/min/1.73 m² Glucose 6.8 mmol/L (4.0–7.8) 12-lead ECG: peaked T waves in the chest leads, flattened P waves, QRS duration 136 ms
Question
Write a prescription for the ONE drug that is most appropriate to give first.
(use the once-only section of the chart)
Your answer: one written prescription, giving the medicine, dose, route and frequency.
Show the answer and markingHide the answer
calcium gluconate 10% solution for injection · 30 mL · intravenous (IV) · once only, given by slow intravenous injection over 10 minutes; repeat if no improvement in the ECG within 5–10 minutes
Marks5 for the drug choice, 5 for the written prescription (dose, route, frequency).
Also creditedcalcium gluconate; calcium chloride; cal gluconate; ca gluconate
Drug choiceSevere hyperkalaemia with ECG changes is two problems in sequence, and the marks here are for knowing the sequence. Problem one is that his myocardium is about to arrest: peaked T waves, flattened P waves and a QRS of 136 ms are the walk to a sine wave. Intravenous calcium fixes none of the potassium and all of the immediate danger — it re-stabilises the membrane within minutes, which is why the BNF's instruction for ECG-change hyperkalaemia is calcium first, with the ECG rechecked at 5–10 minutes and the dose repeated if the trace has not improved. Problem two is the potassium itself, and that is where insulin comes in: 10 units of soluble insulin with 25 g of glucose over 5–30 minutes drives potassium into cells from about 15 minutes. Prescribed FIRST, insulin–glucose leaves the myocardium bare for exactly the quarter of an hour in which this ECG is at its most dangerous — which is why it collects partial credit for drug knowledge and nothing for the prescription. Salbutamol is an adjunct to that second step; the binders (sodium zirconium cyclosilicate, patiromer, the old resin) act over hours in the gut and belong to the non-emergency presentation; bicarbonate treats the acidaemia, not the emergency; furosemide is an afterthought for later.
Dose, route and frequencyThe dose question is the salt question, and the MHRA wrote to every UK prescriber about it in June 2023 after deaths from getting it wrong. Thirty millilitres of calcium GLUCONATE 10% provides approximately 6.8 mmol of calcium — the same calcium as TEN millilitres of calcium CHLORIDE 10%. Two traps follow. First, the 10 mL ampoule of gluconate — the hypocalcaemia dose everyone has seen given — delivers a third of what this ECG needs, and underdosing is the specific error the MHRA advice names. Second, 30 mL written against calcium chloride is a threefold calcium overdose. Give the gluconate by slow intravenous injection over 10 minutes, into a monitored patient, and recheck the ECG at 5–10 minutes: the effect lasts only 30–60 minutes, so a repeat is often needed. Calcium chloride at its correct 10 mL dose loses a single mark here: the BNF prefers gluconate outside cardiac arrest, and chloride is the more irritant salt to push through a 22-gauge cannula in the back of a hand.
ExplanationAlso part of the plan, though not marked in the boxes: insulin–glucose immediately after the calcium, a potassium recheck, holding the ramipril and trimethoprim, and senior renal input at an eGFR of 34.
calcium gluconate 10% solution for injection — 30 mL (approximately 6.8 mmol), intravenous (IV) by slow injection over 10 minutes, once only, repeat if the ECG has not improved at 5–10 minutes. Full marks. Fifteen to 29 mL: 5 + 1. Ten millilitres: 5 + 0. Above 30 mL: 5 + 0. calcium chloride 10% — 10 mL (1 g) IV once only: 5 + 4. Thirty millilitres of the chloride: 5 + 0. insulin–glucose (any spelling) — 2 + 0. 'calcium' with no salt — 2 + 0. salbutamol — 1 + 0. sodium zirconium cyclosilicate, patiromer, calcium polystyrene sulfonate, sodium bicarbonate, furosemide — 0/10. (BNF hyperkalaemia treatment summary and calcium gluconate monograph, including the MHRA/CHM advice of June 2023, read 22 August 2026.)
How this item is marked
Every answer is matched to a marking tier. These are the first rows of this item's real scheme (38 tiers in total).
| Medicine | Dose and route | Marks | Marking note |
|---|---|---|---|
| calcium gluconate | 30 mL · intravenous (IV) | 10 / 10 | optimal. BNF, acute severe hyperkalaemia: 'By slow intravenous injection, Adult: 30 mL for 1 dose, calcium gluconate 10% (providing approximately 6.8 mmol of ca… |
| calcium gluconate | 30 mL · intravenous (IV) | 10 / 10 | the same prescription with the administration time written in the frequency box, which is where a once-only chart's rate instruction often lands. '10 minutes', … |
| calcium gluconate | 3 g · intravenous (IV) | 10 / 10 | the same dose in grams: 30 mL of a 10% solution is 3 g (BNF: calcium gluconate 1 g contains Ca2+ 2.23 mmol; 3 × 2.23 ≈ 6.7 mmol, the monograph's 'approximately … |
| calcium gluconate | 6.8 mmol · intravenous (IV) | 10 / 10 | the same dose written as millimoles of calcium, the MHRA advice's own figure. Credited identically. |
| calcium gluconate | 3 ampoules · intravenous (IV) | 10 / 10 | three 10 mL ampoules of the 10% solution are 30 mL. Credited identically. |
| calcium gluconate | 15-29 mL · intravenous (IV) | 6 / 10 | between the hypocalcaemia dose and the hyperkalaemia dose — most often a remembered '10–20 mL'. Under the 6.8 mmol the ECG needs, on a warning the MHRA issued p… |
| calcium gluconate | 1.5-2.9 g · intravenous (IV) | 6 / 10 | the same intermediate underdose written in grams (15–29 mL of 10%). Deduct 4. |
| calcium gluconate | 1-14 mL · intravenous (IV) | 5 / 10 | the classic error the MHRA's June 2023 advice exists for: the 10 mL hypocalcaemia ampoule given for hyperkalaemia, a third of the calcium the ECG needs. Right d… |
This example on its own page, with the method and checklist →
© 2026 PassthePSA · Question PWS-88 · Free sample for personal study. Copying, republishing or AI training use is not permitted (terms).
A 73-year-old on warfarin with haematemesis and melaena
Case
A 73-year-old man is brought to the emergency department after vomiting fresh blood twice this evening, having passed black tarry stools since this morning. He takes warfarin for atrial fibrillation, and 5 days ago his dentist started an antibiotic for a dental abscess. He is in the resuscitation area: the major haemorrhage protocol has been activated, the transfusion laboratory — which confirms full stocks — has issued red cells, and the first unit is running. Phytomenadione 5 mg has been given by slow intravenous injection and tonight's warfarin is withheld.
PMH: atrial fibrillation; hypertension; dental abscess (5 days ago).
DH: warfarin sodium PO daily (target INR 2.5, usual maintenance 4 mg); metronidazole 400 mg PO three times daily (8-hrly), day 5 of 7 (dental abscess); ramipril 5 mg PO daily; atorvastatin 20 mg PO nightly. No known drug allergies.
SH: retired plumber; lives with his wife; drinks 4 units of alcohol a week; non-smoker.
On examination: Temperature 36.4°C, HR 118/min and irregularly irregular, BP 92/58 mmHg, RR 22/min, O2 sat 96% breathing air. Weight 80 kg. Pale, cool peripheries with a prolonged capillary refill; alert and answering questions. Epigastric tenderness; melaena on rectal examination. Two large-bore cannulae are sited; the first unit of red cells is running through one of them.
Investigations: Hb 72 g/L (130–180) Platelets 256 ×10⁹/L (150–400) Na 138 mmol/L (135–145), K 4.4 mmol/L (3.5–5.3) Urea 14.2 mmol/L (2.5–7.8), creatinine 102 µmol/L (60–120) INR 6.8 (target 2.5) Cross-match: 2 units of red cells issued, further units available
Question
Write a prescription for the ONE additional drug that is most appropriate to reverse his anticoagulation now.
(use the once-only section of the chart)
Your answer: one written prescription, giving the medicine, dose, route and frequency.
Show the answer and markingHide the answer
dried prothrombin complex (four-factor prothrombin complex concentrate, Beriplex® P/N) · 4000 units (50 units/kg) · intravenous (IV) infusion · once only
Marks5 for the drug choice, 5 for the written prescription (dose, route, frequency).
Also crediteddried prothrombin complex; prothrombin complex concentrate; prothrombin complex; PCC; Beriplex; Octaplex
Drug choiceWarfarin reversal in major bleeding is a two-drug algorithm, and the marks here are for the drug that works tonight. The BNF's haemorrhage guidance reads: 'Major bleeding—stop warfarin sodium; give phytomenadione (vitamin K1) by slow intravenous injection; give prothrombin complex (factors II, VII, IX, and X); if prothrombin complex unavailable, fresh frozen plasma can be given but is less effective; recombinant factor VIIa is not recommended for emergency anticoagulation reversal' (BNF, oral anticoagulants treatment summary, read 22 August 2026). The phytomenadione has been given — it switches factor synthesis back on, but synthesis takes hours this haematemesis will not wait for. Dried prothrombin complex IS the missing factors, in a vial: II, VII, IX and X, reconstituted and infused in minutes. Fresh frozen plasma earns partial credit only, because the BNF's condition for it — prothrombin complex unavailable — is printed false: the laboratory is fully stocked, and plasma is slower (thawing), bulkier (a volume load in a shocked man) and weaker (dilute factors). Writing phytomenadione again earns a single mark for knowing the algorithm's other arm: it is already running and the question asks for the ONE additional drug. The zeros are the wrong-patient reversal shelf: idarucizumab reverses dabigatran, andexanet alfa reverses apixaban and rivaroxaban, protamine reverses heparin, and recombinant factor VIIa is the product the BNF's algorithm itself rules out by name.
Dose, route and frequencyThe BNF dose is 25–50 units/kg by intravenous infusion (prothrombin complex monograph, read 22 August 2026) — for this man's printed 80 kg, 2000–4000 units; the model answer takes 50 units/kg = 4000 units, because the Beriplex SmPC's own INR-banded table gives 50 IU/kg for a pre-treatment INR above 6. ('IU' is the SmPC's notation. On a UK prescription 'IU' and 'U' are never written — they are misread as 0 or 10 — and score zero for this half; write 'units' or 'international units' in full.)0 (capped at 5000 IU in patients over 100 kg) and his INR is 6.8. Write 'units'. Any dose from 25 to 50 units/kg sits inside the BNF band and earns full marks. The characteristic dose error is writing a VIAL as a dose: prothrombin complex comes in 500-unit and 1000-unit vials, and 500 units is about 6 units/kg for this man — a token. Under-dosing at 10–24 units/kg loses 4 of the 5 prescription marks; anything above 50 units/kg over-doses a prothrombotic product in a man with atrial fibrillation and scores nothing for the prescription half.
ExplanationAlso part of the plan, though not marked in the boxes: urgent endoscopy once resuscitated, a recheck of the INR after the infusion, stopping the metronidazole interaction review (BNF: 'Metronidazole increases the anticoagulant effect of Warfarin', severity severe), and a documented plan for if and when anticoagulation restarts.
dried prothrombin complex (prothrombin complex concentrate / PCC / Beriplex® P/N / Octaplex®) — 25–50 units/kg (2000–4000 units for 80 kg), intravenous infusion, once only. Full marks. 10–24 units/kg (800–1999 units): 5 + 1. Token doses and doses above 50 units/kg: 5 + 0. fresh frozen plasma (FFP / Octaplas®) — 2 + 0. phytomenadione (vitamin K) — 1 + 0. tranexamic acid — 1 + 0. recombinant factor VIIa, idarucizumab, andexanet alfa, protamine, or any 'PCC or FFP' hedge — 0/10. (BNF oral anticoagulants treatment summary, prothrombin complex and phytomenadione monographs, and metronidazole interactions page, all read 22 August 2026; Beriplex P/N SmPC read the same day.)
How this item is marked
Every answer is matched to a marking tier. These are the first rows of this item's real scheme (65 tiers in total).
| Medicine | Dose and route | Marks | Marking note |
|---|---|---|---|
| dried prothrombin complex | 25-50 units/kg · intravenous (IV) | 10 / 10 | optimal, written per kilogram. BNF, prothrombin complex monograph: 'Major bleeding in patients on warfarin [following phytomenadione] … By intravenous infusion,… |
| dried prothrombin complex | 2000-4000 units · intravenous (IV) | 10 / 10 | the same dose resolved against his printed 80 kg: 25 × 80 = 2000 units, 50 × 80 = 4000 units. Credited identically. |
| dried prothrombin complex | 10-24 units/kg · intravenous (IV) | 6 / 10 | below the BNF's 25 units/kg floor — a partial factor replacement that under-corrects an INR of 6.8. Deduct 4 rather than zero: the drug and route are right and … |
| dried prothrombin complex | 800-1999 units · intravenous (IV) | 6 / 10 | the same underdose written in absolute units (10–24.9 units/kg at 80 kg). Deduct 4. |
| dried prothrombin complex | 1-9 units/kg · intravenous (IV) | 5 / 10 | a token dose — a fraction of any effective regimen. Right drug, failed prescription half. |
| dried prothrombin complex | 1-799 units · intravenous (IV) | 5 / 10 | the remembered vial size (500 or 1000-unit vials exist) written as the dose: under 10 units/kg for this 80 kg man. Zero for the prescription half. |
| dried prothrombin complex | 51-150 units/kg · intravenous (IV) | 5 / 10 | above the 50 units/kg ceiling of a prothrombotic product given to a man with atrial fibrillation. Zero for the prescription half. |
| dried prothrombin complex | 4001-12000 units · intravenous (IV) | 5 / 10 | the same overdose in absolute units. Zero for the prescription half. |
This example on its own page, with the method and checklist →
© 2026 PassthePSA · Question PWS-89 · Free sample for personal study. Copying, republishing or AI training use is not permitted (terms).
Before you submit
- Is the drug I chose the first-line agent for this indication, in this patient?
- Is the dose taken from the right indication in the monograph?
- Have I written a dose in a unit, not a volume?
- Does the route exist for this drug and this form?
- Is there a frequency, and is it in the chart's words?
- Have I checked renal function, allergy and the interaction the case mentions?
Practise this section
Practise Prescribing on its own, or meet it in exam proportions inside a full mock paper. The practice questions are written to reflect the PSA's format and marking closely; PassthePSA is independent of the assessment provider.
Practise Prescribing questions 187 questions, each with a full explanation
Section sizes and marks follow the published PSA blueprint. The BNF headings named here are the current online BNF's. Check any dose or threshold against the BNF before you rely on it; this page teaches the method, the BNF holds the numbers.